ReneSola Ltd. (NYSE:SOL), a leading brand and technology provider of solar photovoltaic (“PV”) products, as previously announced, will report its unaudited financial results for the fourth quarter and full year ended December 31, 2013 before the U.S. markets open on Monday, March 24, 2014. ReneSola Ltd. (ADR) (NYSE:SOL) shares after opening at $4.19 moved to $4.19 on last trade day and at the end of the day closed at $3.87. Company price to sales ratio in past twelve months was calculated as 0.25 and price to cash ratio as 3.65. ReneSola Ltd. (ADR) (NYSE:SOL) showed a positive weekly performance of 1.84%.
Stock analysts at Deutsche Bank lowered their price target on shares of Yingli Green Energy Hold. Co. (NYSE:YGE) from $10.00 to $8.00 in a report issued on Wednesday, AnalystRatings.NET reports. Deutsche Bank’s target price suggests a potential upside of 65.98% from the stock’s previous close. Yingli Green Energy Hold. Co. Ltd. (ADR) (NYSE:YGE) shares fell -5.37% in last trading session and ended the day on $4.76. YGE return on equity ratio is recorded as -140.00% and its return on assets is -8.60%. Yingli Green Energy Hold. Co. Ltd. (ADR) (NYSE:YGE) yearly performance is 105.17%.
Novavax (NASDAQ:NVAX) major shareholder Pharmaceuticals Ltd Cadila sold 3,000,000 shares of Novavax stock on the open market in a transaction dated Friday, March 21st. The stock was sold at an average price of $4.95, for a total transaction of $14,850,000.00. Novavax, Inc. (NASDAQ:NVAX) shares moved down -5.65% in last trading session and was closed at $4.68, while trading in range of $4.46 – $5.00. Novavax, Inc. (NASDAQ:NVAX) year to date (YTD) performance is -8.59%.
Sangamo Biosciences, Inc. (NASDAQ:SGMO) on Mar. 20 announced the pricing of an underwritten public offering of common stock consisting of 4,444,444 shares at a public offering price of $22.50 per share. Sangamo Biosciences, Inc. (NASDAQ:SGMO) weekly performance is -7.34%. On last trading day company shares ended up $21.35. Sangamo Biosciences, Inc. (NASDAQ:SGMO) distance from 50-day simple moving average (SMA50) is 7.71%. Analysts mean target price for the company is $27.33.
Leave a Reply